NE-U04/NE U04F
510(k) K923024
Active
510(k)
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Overview
A comprehensive medical device directory entry for the NE-U04/NE U04F Nebulizer (Direct Patient Interface) device, providing detailed information on its features, compliance, and regulatory status.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK923024 | Date15 Sep 1992 | StatusActive |
Official records
- FDA 510(k) database K923024
From the FDA record
- Received by the FDA
- 23 Jun 1992
- FDA decision
- 15 Sep 1992 (Substantially Equivalent)
- FDA review time
- 84 days from receipt to decision
- Public document
- 510(k) statement on file with the FDA
Recalls
-
- Terminated Z-0382-05
A potential failure of the vibrating mechanism of the medication bottle which causes a failure to transmit vibration and results in no nebulization.
Timeline
- Cleared FDA 510(k) K923024
- Recall initiated FDA recalls Z-0382-05
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- CAF
- Device class
- Class II
- Regulation
- 21 CFR Part 868.5630
- Advisory committee
- Anesthesiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code CAF (Nebulizer (Direct Patient Interface)).
- MASTER-NEB NEBULIZER COMPRESSOR SYSTEM by Howard K. Mann & Assoc.
- Nebulizing Elbow Entrainment Elbow Nebulizing Elbow Kit 1119028 by Respironics Inc.
- QUIXIE NEBULIZER by ODYSSEY MEDICAL TECHNOLOGIES, LLC
- AdheResp Smart Breath-actuated Mesh Nebulizer by HCMED INNOVATIONS CO., LTD.
- BETAMIST 2 by Rantran, Inc.
- AQUAPAK NEBULIZER ADAPTORS/RESERVOIRS by Teleflex Medical, LLC
- STEALTH PILOT KIT/ STEALTH SPACER/FACE MASK KIT by Dhd Healthcare Corp.
- Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7% by Mankind Pharma Limited
- AERONEB II, MODEL APN 200 by Aerogen, Inc.
- EASIMIST ULTRASONIC NEBULIZER by Medix Corp.